×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [8]
内容类型
期刊论文 [8]
发表日期
2022 [3]
2021 [5]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共8条,第1-8条
帮助
限定条件
内容类型:期刊论文
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial
期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/22
First-in-human, phase I study of AK109, an anti-VEGFR2 antibody, in patients (pts) with advanced or metastatic solid tumors.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Xu, Nong
;
Zheng, Yulong
;
Zhong, Haijun
;
Zhao, Fuyou
;
Zhou, Huan
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/23
Short-term outcomes of laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): A multicenter, randomized, controlled trial.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Chi, Pan
;
Su, Xiangqian
;
Xu, Jianmin
;
Qiu, Huizhong
;
Wang, Ziqiang
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Updated safety and efficacy of MSB2311 (an anti-programmed death-ligand 1 antibody) in Chinese patients with advanced solid tumors and hematological malignancies from a phase 1 study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Shen, Lin
;
Gong, Jifang
;
Zhang, Jian
;
Ji, Dongmei
;
Zhong, Haijun
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/01/10
Prolonged overall survival observed in patients with locally advanced gastric cancer receiving prophylactic simplified heated intraperitoneal chemotherapy after D2 surgery.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Cheng, Junchi
;
Yang, Yunshan
;
Zhong, Haijun
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2022/01/10
Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/01/10
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Qin, Shukui
;
Li, Jin
;
Zhong, Haijun
;
Jin, Chuan
;
Chen, Lili
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/01/10
Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Li, Jin
;
Qin, Shukui
;
Wen, Lu
;
Wang, Junsheng
;
Deng, Wenying
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/01/10
©版权所有 ©2017 CSpace - Powered by
CSpace